Intra-amygdala infusion of the non-N-methyl-D-aspartate (NMDA) receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) prior to testing impairs inhibitory avoidance retention test performance. Increased training attenuates the impairing effects of amygdala lesions and intra-amygdala infusions of CNQX. The objective of the present study was to determine the effects of additional training on the impairing effects of intra-amygdala CNQX on expression of the inhibitory avoidance task. Adult female Wistar rats bilaterally implanted with cannulae into the border between the central and the basolateral nuclei of the amygdala were submitted to a single session or to three training sessions (0.2 mA, 24-h interval between sessions) in a step-down inhibitory avoidance task. A retention test session was held 48 h after the last training. Ten minutes prior to the retention test session, the animals received a 0.5-µl infusion of CNQX (0.5 µg) or its vehicle (25% dimethylsulfoxide in saline). The CNQX infusion impaired, but did not block, retention test performance in animals submitted to a single training session. Additional training prevented the impairing effect of CNQX. The results suggest that amygdaloid non-NMDA receptors may not be critical for memory expression in animals given increased training.
of fear memory. Long-term potentiation (LTP) at glutamatergic synapses is the leading candidate as a neural plasticity mechanism that underlies memory processing by the amygdala (1) (2) (3) (4) (5) (6) (7) (8) (9) . LTP induction depends on N-methyl-D-aspartate (NMDA) glutamate receptor channels, and expression of LTP depends on non-NMDA glutamate receptors (10) . Infusions of NMDA receptor antagonists into the amygdala block retention of fear conditioning (2) , fear-potentiated startle (1, 4) and inhibitory avoidance (6, 8, 9, 11) . Furthermore, intra-amygdala infusions of the non-NMDA receptor antagonist 6-cyano-7nitroquinoxaline-2,3-dione (CNQX) prior to testing impair both inhibitory avoidance (5, 7, 8) and fear-potentiated startle (3) . These data are consistent with the view that the amygdala participates in the acquisition and storage of aversively motivated memory through LTP. Another view regarding the role of the amygdala in memory is that it is a modulatory site which regulates memory storage and/or consolidation in other brain regions (12) . This view is supported by evidence that amygdaloid lesions do not block retention of inhibitory avoidance (13) or escape training responses (14) . Furthermore, the findings that increased training attenuates the impairing effects of amygdaloid lesions (14) and of intra-amygdala infusions of CNQX given prior to the test (15) on escape training response support the view that the amygdala is a modulatory site rather than a critical storage site for memory. If the amygdala were a critical site for storage and retrieval, amygdaloid lesions and intra-amygdala infusions of CNQX would block memory regardless of the extent of original training (14, 15) . Intra-amygdala infusion of CNQX prior to testing is known to impair retention of step-down inhibitory avoidance, a fearmotivated memory task (5, 7, 8) . To investigate the effects of increased training on intra-amygdala CNQX-induced memory impairment, we examined inhibitory avoidance retention in rats given additional training sessions and infused with CNQX into the amygdala prior to the retention test session.
Adult female Wistar rats (180-230 g) were housed 5 to a cage with free access to water and food, and maintained on a 12-h light-dark cycle (lights on at 7:00 a.m.) at a temperature of 23 ± 1 o C. Behavioral proce-dures took place in the afternoon.
Animals were bilaterally implanted under thionembutal anesthesia (30 mg/kg, ip) with guide cannulae aimed 1.0 mm above the border between the central and the basolateral nuclei of the amygdala (5-9). Stereotaxic coordinates were A -2.3, L 4.5, V -7.4, according to the atlas of Paxinos and Watson (16) .
Animals were submitted to a single training session or to three training sessions followed by a retention test session in a stepdown inhibitory avoidance task. For the animals submitted to a single training session, the training-test interval was 48 h. In animals submitted to three training sessions, the interval between training sessions was 24 h, and the interval between the third training session and the test session was 48 h. The inhibitory avoidance apparatus was an automatically operated, brightly illuminated box as described elsewhere (5) (6) (7) (8) (9) . The left end of the grid was covered with a 7.0-cm wide, 2.5-cm high formica platform. Animals were placed on the platform and their latency to step-down with the four paws on the grid (a 42.0 x 25.0-cm grid of parallel 0.1-cm caliber stainless steel bars spaced 1.0 cm apart) was measured. In the training sessions, immediately after stepping down, the animals received a 0.2-mA, 2-s scrambled footshock. No footshock was given in the test sessions. A ceiling of 300 s was imposed on stepdown latencies. Thus, values equal to or higher than 300 s were counted as 300 s. The interval between sessions was 24 h. Ten minutes prior to the test session, a 30-gauge injection cannula was fitted into the guide cannula, and animals were given a 0.5-µl infusion of vehicle (25% dimethylsulfoxide in saline) or CNQX (5.0 µg) dissolved in the vehicle as previously described (5, 7, 8) .
After the retention test sessions, animals were sacrificed by decapitation, and cannula placements were verified post-mortem by histological examination as described elsewhere (5) (6) (7) (8) (9) . Cannulae were found to be correctly placed 1.0 mm above the border between the central and the basolateral nuclei of the amygdala in 24 vehicle-treated rats and 20 CNQX-treated rats (data not show). Data from animals with misplaced cannulae were not included in the final analysis.
Data are reported as median (interquartile range) latency to step-down. In animals submitted to a single training session, training and test session latencies were compared by the Wilcoxon test. In animals submitted to three training sessions, enhancement of performance across consecutive sessions was analyzed by Friedman two-way analysis of variance, and the third training and test session latencies were compared by the Wilcoxon test. Comparisons between different groups were made by the Mann-Whitney test; P<0.05 was considered to indicate statistical significance.
Results of the single-training experiment are shown in Table 1 . There was no difference between groups in training session latencies (P>0.10, Mann-Whitney test). There was a significant difference between groups in test session latencies (P<0.05, Mann-Whitney test), and there were significant differences between training and test session latencies in both vehicle and CNQX groups (P<0.05, Wilcoxon test), indicating that intraamygdala CNQX attenuated, but did not completely block, inhibitory avoidance retention.
Animals submitted to three training sessions significantly improved performance across consecutive sessions (P<0.01, Friedman two-way analysis of variance) ( Table  2 ). There were no differences in latencies between groups (P>0.10, Mann-Whitney test). There were no significant differences between third training and test session latencies in any group (P>0.10 for the vehicle group and P = 0.09 for the CNQX group, Wilcoxon test). The results suggest that intra-amygdala CNQX did not affect inhibitory avoidance retention in animals submitted to three training sessions. The findings of the present experiments indicate that additional training prevents the impairing effect of intra-amygdala infusion of CNQX given prior Table 1 -Median (interquartile range) of latencies to step-down of rats trained and tested in a step-down inhibitory avoidance task (0.2-mA footshock; 48-h interval between sessions).
Animals received bilateral intra-amygdala 0.5-µl infusions of vehicle (25% DMSO in saline) or CNQX (0.5 µg) 10 to test. Consistent with previous findings (5, 7, 8) , intra-amygdala CNQX attenuated, but did not block, inhibitory avoidance retention when given 10 min prior to test. This indicates that amygdaloid non-NMDA receptors are involved in retrieval of that task. However, the finding that additional training prevented the effect of CNQX suggests that non-NMDA receptor activation in the amygdala is not a critical mechanism of retrieval, and that the amygdala is not a critical site of storage and retrieval of fear-motivated memory. This is consistent with previous evidence that increased training attenuates the impairing effects of amygdaloid lesions (14) and intra-amygdala CNQX (15) on an aversively motivated escape training response. In previous reports, increased training attenuated, but did not prevent, the effects of amygdala lesions and intra-amygdala CNQX, even in animals submitted to 10 or 20 training trials (14, 15) . However, our results show that 3 training trials were sufficient to pre-vent the impairing effect of CNQX, as shown by the finding that CNQX-treated animals given 3 training trials had retention test latencies comparable to control animals given 3 training trials. It is possible that differences between tasks could explain this discrepancy. One interesting possibility is that an increased amount of training is more effective in preventing the effects of memoryimpairing treatments when trials are separated by a 24-h interval (present study) than when several trials are given consecutively in a single training session, as in previous studies (14, 15) .
The major finding of the present report is that additional training prevents the impairing effect of intra-amygdala infusion of CNQX on retention of the step-down inhibitory avoidance task. This suggests that the amygdala participates in fear-motivated memory through a non-NMDA receptor-dependent mechanism as a modulatory site, rather than as a critical site for storage and retrieval.
